The Toulouse-Oncopole Cancer University Institute and Airbus have just signed a partnership agreement.
The objective is to put the knowledge of the aircraft manufacturer's engineers in the field of artificial intelligence and big data at the service of cancer research.
What do Airbus, the largest aircraft manufacturer in the world, and the Oncopole de Toulouse, a leading hospital and research center in the fight against cancer, have in common?
At first glance, their work is at odds with each other.
But despite appearances, their location in the Pink City is far from being their only point of convergence.
Whether tracking the thousands of planes that fly across the skies every day or analyzing millions of cancer cells, they are increasingly faced with data management.
To make progress on these issues, the European aircraft manufacturer and the institute signed a partnership agreement on Wednesday.
“At the hospital, we use complex data, from the life course of patients, data from examinations, radiology, scanners, microscopy images.
There is a real subject which is common with a certain number of manufacturers, in particular Airbus, that of the contribution of engineering sciences to artificial intelligence programs", assures Professor Jean-Pierre Delord, to head of the Toulouse-Oncopole Cancer University Institute.
A win-win partnership
The doctors and researchers of the Institute will thus work together with the engineers of Airbus, at the forefront in this field.
Because today, as in many industries, digital is taking an increasingly important place in aeronautics.
“Over the past few years, we have developed digital analysis tools, such as the system that tracks and retrieves all flight data from thousands of aircraft around the world and helps improve flight operations.
We have acquired new skills in the field of big data and artificial intelligence.
We realized during our exchanges with Prof. Delord that this was also a very important area of modern medicine and research in the fight against cancer.
We therefore decided to create this cooperation”, confirms Marc Hamy,
The group had already made inroads into the medical world during the Covid-19 period, adapting diving masks for caregivers to make them more efficient or taking part in the development of respirators.
This time, it is its know-how in embedded systems and dialogues between different interfaces that will be deployed.
In particular to develop technological tools that will help doctors make decisions when faced with MRIs, CT scans or biological results of the patient.
“We are convinced that Airbus has things to learn from the Oncopole also because artificial intelligence technologies are developing very quickly in medicine.
It will be up to our engineers, researchers and doctors from the Oncopole to identify joint study projects.
We will see the means to be implemented according to the projects identified and what type of specific agreement this can give”, concludes Marc Hamy.
Health
Childhood cancer: An innovative treatment for the pain of a side effect of chemo
Health
Cancer: We now know where T lymphocytes go to access and destroy tumors
Artificial intelligence
Research
Data
Cancer
Airbus
Toulouse
Health
0 comment
0 share
Share on Messenger
Share on Facebook
Share on Twitter
Share on Flipboard
Share on Pinterest
Share on Linkedin
Send by Mail
To safeguard
A fault ?
To print